China Insider: WHO Promotes Unfinished Vaccines Developed by the CCP

CCP Censors Pence’s Debate Comments Critical of Communist Regime Giuliani: I Hold China Responsible for What Happened to Trump In an interview with the Epoch Times on Tuesday, former New York City Mayor and President Trump’s personal attorney Rudy Giuliani said he holds China responsible for President Donald Trump becoming infected with the Chinese Communist Party (CCP) virus. The CCP virus outbreak began in Wuhan, China, in late 2019. The CCP’s attempts to cover up the contagion and the regime’s overall negligence contributed to the global outbreak of the virus.  Chinese Immigrant: We Are In the Final Battle Against the CCP The U.S. Citizenship and Immigration Services (USCIS) recently announced that any “intending immigrant who is a member or affiliate of the Communist Party” or affiliated with the Communist Party, “is inadmissible to the United States.” Many Chinese who have followed the advice of Falun Gong practitioners and quit the Chinese Communist Party felt fortunate for themselves. Falun Gong practitioners believe that the whole world is fighting the final battle in taking down the CCP, and are urgently urging more Chinese to quit the CCP as soon as possible.  WHO promotes unfinished vaccines developed by the CCP On October 6, the WHO disclosed at a press conference that the CCP is in contact with them, requesting an assessment of its locally-produced COVID-19 vaccines, as a step toward making them available for international use. This news has caused widespread concern since the vaccine has not yet completed large-scale clinical trials and safety testing. According to Reuters’ news on October 6, Socorro Escalate, WHO’s coordinator for essential medicines and health technologies in the Western Pacific region, told a news conference conducted online that China had held preliminary discussions with the WHO to have its vaccines included in a list for emergency use. The WHO’s emergency use listing procedure allows unlicensed vaccines and treatments to be assessed to expedite their availability in public health emergencies.